Get informed when a big investor buys or sells
+ Follow-190.24%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Aptamer Group plc (APTA.L) currently reports a ROE of -190.24%. That is below the Healthcare sector average of -100.59%. Use the charts on this page to explore Aptamer Group plc's ROE history and peer comparisons.
Aptamer Group plc's ROE of -190.24% is lower than the Healthcare sector average of -100.59%. That is roughly 89.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Aptamer Group plc's current -190.24% should be judged against Healthcare norms (sector average: -100.59%) and against APTA.L's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -190.24%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is -100.59%. From there, open related valuation or income-statement pages for Aptamer Group plc, and consider following APTA.L for alerts when major investors trade the stock.
Aptamer Group plc is classified in the Healthcare sector. On ROE, it currently shows -190.24% versus a sector average near -100.59%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing APTA.L with unrelated industries.